Negative Pressure Wound Therapy
Wound VAC and negative pressure wound management systems.
Market snapshot
These figures describe Wound Care & General Surgery Devices (4.8.13), the segment that Negative Pressure Wound Therapy sits within — not Negative Pressure Wound Therapy on its own.
- Market size
- ~$38B
- Growth
- ~2.6%CAGR (2017–22, nominal)
- Companies
- ~1,800
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 339113 (Surgical Appliance & Supplies Manufacturing).
Business model & economics
Revenue model
Device and recurring-consumable sales
Key economics
- Recurring revenue
- High
- EBITDA margin
- 18–28%
- Capex intensity
- High
recurring dressings and consumables
Characteristics
- Aging, diabetes, and chronic-wound prevalence drive demand.
- Advanced and biologic wound products the higher-value tier.
- Devices plus recurring consumables.
Geographic concentration
Wound-care and general-surgery device manufacturing concentrates in Minnesota, Indiana, and Pennsylvania, building on each state's medical-device manufacturing base.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 339113. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Wound-care & surgery strategics
- Diversified medtech platforms
- PE-backed device companies
What’s driving deals
- Acquisition of advanced and biologic wound products.
- Chronic-wound prevalence demand.
- Recurring-consumable economics.
Find Negative Pressure Wound Therapy acquisition targets
Search Acquisera’s index for companies classified under Negative Pressure Wound Therapy (4.8.13.3) and build a targeted deal pipeline.
Search companies